Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» CRISPR biotech Intellia strikes licensing deal with Regeneron, readies IPO
CRISPR biotech Intellia strikes licensing deal with Regeneron, readies IPO
CRISPR biotech Intellia strikes licensing deal with Regeneron, readies IPO
Submitted by
admin
on April 11, 2016 - 11:22pm
Source:
BioPharma Dive
News Tags:
CRISPR
Intellia Therapeutics
Regeneron
IPOs
Headline:
CRISPR biotech Intellia strikes licensing deal with Regeneron, readies IPO
Do Not Allow Advertisers to Use My Personal information
